MERRILL D. BENSON, M.D., F.A.C.P.; MARTHA SKINNER, M.D.; ALAN S. COHEN, M.D.; F.A.C.P.
A patient with familial Mediterranean fever and amyloidosis who received a cadaver renal transplant 6½ years ago was studied to determine the relation of the serum precursor of secondary amyloid (SAA) to the clinical course and to the deposition of amyloid in the transplant. Amyloid fibrils extracted from the patient's kidneys contained protein AA as a major constituent, which identified the amyloid as secondary. Protein AA antiserum was used in an indirect immunofluorescent technique to stain amyloid deposits in sections of the original kidney. A renal biopsy at 2 years showed no amyloid, but a renal biopsy at 4 years showed amyloid. Serum levels of SAA from 3 years before transplant to 6 years after transplant were elevated throughout most of the course.
BENSON MD, SKINNER M, COHEN AS. Amyloid Deposition in a Renal Transplant in Familial Mediterranean Fever. Ann Intern Med. ;87:31–34. doi: 10.7326/0003-4819-87-1-31
Download citation file:
Published: Ann Intern Med. 1977;87(1):31-34.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use